Reminder - Biosite Announces Presentation at the Third Annual GARP Investor Conference
May 17 2006 - 8:15AM
PR Newswire (US)
SAN DIEGO, May 17 /PRNewswire-FirstCall/ -- Biosite Incorporated
(NASDAQ:BSTE) today announced that Kim Blickenstaff, chairman and
chief executive officer, and Ken Buechler, president and chief
scientific officer, will discuss the Company's operating
environment, new and potential products and the Company's research
and development activities at the Third Annual GARP Investor
Conference at the InterContinental Harbor Court Hotel in Baltimore.
Biosite's presentation will take place Wednesday, May 17, 2006, at
4:00 p.m. EDT. A link to the live audio webcast can be accessed
through the Biosite website, http://www.biosite.com/. The Biosite
presentation will be archived on the website until June 7, 2006 in
the Investor Center under Events Calendar. About Biosite
Incorporated Biosite Incorporated is a leading bio-medical company
commercializing proteomics discoveries for the advancement of
medical diagnosis. The Company's products contribute to
improvements in medical care by aiding physicians in the diagnosis
of critical diseases and health conditions. Biosite's Triage(R)
rapid diagnostics are used in approximately 50 percent of U.S.
hospitals and in more than 60 international markets. Information on
Biosite can be found at http://www.biosite.com/. Biosite(R),
Triage(R) and New Dimensions in Diagnosis(R) are registered
trademarks of Biosite Incorporated. The Company's logo is a
trademark of Biosite Incorporated. DATASOURCE: Biosite Incorporated
CONTACT: Nadine Padilla, Vice President, Corporate and Investor
Relations of Biosite Incorporated, +1-858-805-2820, Web site:
http://www.biosite.com/ Company News On-Call:
http://www.prnewswire.com/comp/116737.html
Copyright
Biosite (NASDAQ:BSTE)
Historical Stock Chart
From Jun 2024 to Jul 2024
Biosite (NASDAQ:BSTE)
Historical Stock Chart
From Jul 2023 to Jul 2024